Alnylam Pharmaceuticals (ALNY) EPS (Basic) (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.52% |
| Dec 31, 2025 | -56.02% |
| Sep 30, 2025 | 474.51% |
| Jun 30, 2025 | -264.29% |
| Mar 31, 2025 | 78.46% |
| Dec 31, 2024 | 25.29% |
| Sep 30, 2024 | -569.23% |
| Jun 30, 2024 | 75.00% |
| Mar 31, 2024 | 52.29% |
| Dec 31, 2023 | -192.37% |
| Sep 30, 2023 | 153.39% |
| Jun 30, 2023 | -57.86% |
| Mar 31, 2023 | 16.67% |
| Dec 31, 2022 | 49.40% |
| Sep 30, 2022 | -44.98% |
| Jun 30, 2022 | -14.50% |
| Mar 31, 2022 | 7.41% |
| Dec 31, 2021 | -25.58% |
| Sep 30, 2021 | -6.83% |
| Jun 30, 2021 | 5.85% |
| Mar 31, 2021 | 18.18% |
| Dec 31, 2020 | 4.13% |
| Sep 30, 2020 | -39.74% |
| Jun 30, 2020 | 3.70% |
| Mar 31, 2020 | 34.41% |
| Dec 31, 2019 | -28.65% |
| Sep 30, 2019 | 4.95% |
| Jun 30, 2019 | -16.76% |
| Mar 31, 2019 | 17.22% |
| Dec 31, 2018 | 13.99% |
| Sep 30, 2018 | -49.08% |
| Jun 30, 2018 | -15.60% |
| Mar 31, 2018 | 4.73% |
| Dec 31, 2017 | -10.45% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | -7.20% |
| Mar 31, 2017 | 5.30% |
| Dec 31, 2016 | -9.09% |
| Sep 30, 2016 | -15.24% |
| Jun 30, 2016 | 13.22% |
| Mar 31, 2016 | -13.08% |
| Dec 31, 2015 | -17.58% |
| Sep 30, 2015 | -7.06% |
| Jun 30, 2015 | -37.10% |
| Mar 31, 2015 | -121.43% |
| Dec 31, 2014 | 51.72% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 84.32% |
| Mar 31, 2014 | -625.49% |
| Dec 31, 2013 | -6.25% |
| Sep 30, 2013 | -65.52% |
| Jun 30, 2013 | -93.33% |
| Mar 31, 2013 | 87.50% |
| Dec 31, 2012 | -215.79% |
| Sep 30, 2012 | -52.00% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | 24.24% |
| Dec 31, 2011 | -6.45% |
| Sep 30, 2011 | 6.06% |
| Jun 30, 2011 | 13.16% |
| Mar 31, 2011 | -123.53% |
| Dec 31, 2010 | 26.09% |
| Sep 30, 2010 | 34.29% |